4th Annual State of the Art Lung Nodule Symposium 2025: Current Perspectives & Future Directions
This symposium is designed to deepen your expertise in the diagnosis, management, and treatment of lung nodules. Attendees will explore the latest advancements, research, and best practices in the field. In addition to educational sessions, the event offers valuable networking opportunities with fellow physicians, nurses, and pharmacist and other healthcare professionals. Participants will gain practical tools and insights that can be immediately applied in clinical practice. The symposium emphasizes the importance of staying current in a rapidly evolving specialty.
This conference is being held in person/virtually.
NOTE: Please note this activity will be presented 7:30am – 4:30pm CST / 8:30am - 5:30pm EST
Target Audience
This activity is designed for physicians, nurses, pharmacists, and other healthcare professionals.
Learning Objectives
At the end of this session, learners should be able to:
- Apply evidence-based practices in the diagnosis, imaging, and management of lung nodules, including updates on screening protocols and advanced imaging techniques.
- Evaluate emerging technologies such as AI-driven risk stratification, optical coherence tomography, and confocal laser endomicroscopy for their clinical utility in lung nodule assessment.
- Compare multidisciplinary approaches to lung nodule treatment, including interventional pulmonology, thoracic surgery, and intratumoral therapies, to optimize patient outcomes.
AGENDA
07:30-08:00 | Registration, Continental Breakfast, Exhibit Fair |
07:45- 08:00 | Welcome and Introduction |
08:00- 08:20
| Lung Cancer Screening Update: We Found a Lung Nodule, Now What to Do? (Pulmonary Nodule Risk Stratification) |
08:20 – 08:40
| Beyond the Numbers: Redefining Diagnostic Yield in Lung Nodule Assessment |
08:40– 09:00
| The Evolving Role of Advanced Imaging in Lung Nodule Diagnosis |
9:00-9:20
| CT-to-Body Divergence in Bronchoscopy: Strategies and Anesthesia Considerations |
9:20-9:40
| Intratumoral Therapy of Thoracic Malignancies |
9:40-10:00 | AI-Driven Approaches to Lung Nodule Risk Stratification |
10:00– 10:20 | Coffee Break / Exhibit Fair |
10:20– 10:40 | Next-Generation Imaging in Peripheral Bronchoscopy: Application of OCT, CLE, and Beyond |
10:40– 11:00 | Ground Glass Nodules: Biopsy Now or Watchful Waiting? |
11:00– 11:20 | European Approach to Lung Nodules |
11:20– 11:40 | From Low to High: Tips and Tricks for a Better Diagnostic Yield |
11:40-12:00 | Tool-in-Lesion Confirmation: The Future is Now |
12:00 – 12:40
| Lunch Break / Exhibit Fair |
12:40-1:00 | Liquid Biopsy vs. Re-biopsy: An Interventional Pulmonology Perspective |
1:00-1:20 | Fiducial Marking in Pulmonary Nodules: Facilitating Lung-Sparing Surgery |
1:20-1:40 | Back to the Basics- The Role of Thin and Ultrathin Bronchoscopy in the Era of Robotics |
1:40- 2:00
| From Frozen Edges to Burning Cores: Updates in Lung Nodule Ablation |
2:00-2:20 | Break / Exhibit Fair |
2:20-2:40 | From Heat and Ice to Pulsed Electricity: Redefining Pulmonary Ablation Essam Mekhaiel, MD, FCCP, DAABIP |
2:40-3:00 | From Detection to Resection: The Surgical Perspective in Early-Stage Lung Cancer |
3:00-3:20
| Year In Review |
3:20-3:40
| Discussion and Q&A |
3:40-4:20 | Panel Discussion 1. Pre-Procedural Imaging in the Era of Robotic Bronchoscopy: Is Cone Beam CT Enough 2. Biomarkers in the Management of Lung Nodules 3. Should Nodules Less Than 8 mm Be Biopsied? Revisiting Fleischner Guidelines 4. Management of Multifocal or Bilateral Nodules (Surgical Candidacy or Ablative Therapy Planning) 5. What Is an Acceptable Diagnostic Yield in 2025/2026? |
4:20-4:30 | Closing Remarks |
Faculty
Essam Mekhaiel, MD, FCCP, DAABIPl Interventional Pulmonologist & Pulmonary Critical Care Physician; Director of Interventional Pulmonology; Advocate Christ Medical Center
Emily Ball, PharmD, BCCCP; Medical ICU Clinical Pharmacy Specialist; Advocate Christ Medical Center
Ashley Lemmon, MSN, RN, CAPA; Coordinator, Medical Staff Professional Development; Advocate Southland PSA: Advocate South Suburban Hospital/Advocate Christ Medical Center/Advocate Trinity Hospital
Daniel Sterman, MD; Thomas & Suzanne Murphy Professor of Pulmonary & Critical Care Medicine; Director, Division of Pulmonary, Critical Care & Sleep Medicine; Director, Multidisciplinary Pulmonary Oncology Program; Principal Investigator, NYU Pulmonary Oncology Research Team (NYU PORT); Departments of Medicine & Cardiothoracic Surgery
Kevin Haas, MD; Associate Professor of Clinical Medicine- Division of Pulmonary, Critical Care, Sleep and Allergy; Associate Program Director- Pulmonary and Critical Care Fellowship; Director, Interventional Pulmonary
Septimiu Murgu, MD, FCCP, DAABIP; Professor of Medicine; University of Chicago
Joseph Mammarappallil, MD, PhD; Associate Professor, Cardiothoracic Division - Department of Radiology; Duke University Medical Center
Alexander Chen, MD; Director, Interventional Pulmonology Associate Professor, Division of Pulmonary and Critical Care Medicine; Associate Professor of Surgery, Division of Cardiothoracic Surgery ; Washington University School of Medicine
Ali Sadoughi, MD; Director of Interventional Pulmonology and Bronchoscopy Services; Associate Professor of Medicine; Montefiore Medical Center- Albert Einstein College of Medicine
Hasnain Bawaadam MD, MPH, FCCP, FRCP, D-AABIP; Medical Director for Interventional Pulmonary and Respiratory Care Services-Department of Interventional Pulmonology and Critical Care; Aurora Medical Center- Kenosha; Associate Professor of Medicine, Rosali
Paul Gordon, MD; Thoracic Surgeon, Director Thoracic Oncology; Advocate Christ Medical Center
Sonali Sethi, MD, FCCP; Director, Lung Cancer Diagnosis and Staging Program; Program Director for Interventional Pulmonary Fellowship & Fellows Procedural Training; President-Elect American Association of Bronchology and Interventional Pulmonology; Respiratory Institute - Department of Pulmonary, Allergy and Critical Care Medicine & Transplant Center; Cleveland Clinic
Momen Wahidi, MD, MBA; Professor of Medicine; Medical Director; Health System Director, Interventional Pulmonology; Clinical Practice Director, Division of Pulmonary and Critical Care; Co-Medical Director, Northwestern Medicine Lung Cancer Screening Program; Northwestern Feinberg School of Medicine
Thomas Gaisl, MD, MPH, PhD; Interventional Pulmonology; Universitätsspital Zürich, Switzerland
Fabien Maldonado, MD, MSc; Professor of Medicine and Thoracic Surgery; Pierre Massion Director in Lung Cancer Research; Director of Interventional Pulmonology; Vanderbilt Interventional Pulmonology Research, director; MASLAB, co-director; Vanderbilt University
Uzair Ghori, MD, DABIP; VA Milwaukee Interventional Pulmonary Director; PCCM/ CCM Fellowship VA Site Director; PCCM/ CCM Fellowship VA Site Director; Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine; Medical College of Wisconsin
Disclosure
Faculty disclosures are being reviewed and will be presented to the audience in advance of the program.

Accreditation Statement
In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Statement(s)
American Medical Association (AMA)
Advocate Health designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Advocate Health designates this live activity for a maximum of 6.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Council for Pharmacy Education (ACPE)
Advocate Health designates this live activity for a maximum 6.75 hours of CPE credit for (pharmacists and pharmacy technicians). CPE credit can be claimed on the AAH CE platform within 60 days of activity completion and information will be provided to CPE Monitor. Participants should only claim credit commensurate with the extent of their participation in the activity.
Board Recognition Statement(s)
American Board of Internal Medicine
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Available Credit
- 6.75 American Board of SurgerySuccessful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery's Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
- 6.75 ABS Self-Assessment
- 6.75 AMA PRA Category 1 Credit™Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 6.75 AttendanceAttendance Credit
- 6.75 Approved AMA PRA Category 1 Credit™
- 6.75 Continuing Nursing Education (CE)Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 6.75 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
- 6.75 Continuing Pharmacy Education (CPE)Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 6.75 Continuing Pharmacy Education (CPE) Pharmacy TechnicianAurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 6.75 ABIM MOC Part IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Price
How to Register
Complete the form above and click "Add to cart."
Click "Checkout" and follow the prompts to complete your order.
For those attending this in person; the conference will be held at Advocate Christ Medical Center, Oak Lawn, IL
For those attending this conference virtually, a link to the meeting will be provided prior to the event
| FEE | |
| Physician/ Pharmacists | $150.00 |
| Advanced Practice Providers | $50.00 |
| Nurses/Residents/Fellows | Free |
Payable by credit card only
Registration for this activity can only be completed through the CE Learning Platform. Attendee registrations made through any other sites cannot be honored.
If you need a coupon code, please contact Ashley Lemmon at [email protected]
Cancellation and Refund Policy
Cancelation/Refunds/Substitutions
- Cancellations must be in writing (email)
- Registrants cancelling between two weeks and five full business days prior to the first day of the event are "refunded at 70% of the registration fee subject to a minimum $25 cancellation fee."
- No refunds or credits will be given for cancellations received less than five full business days prior to the event.
- No refunds or credit will be given for no-shows.
- No vouchers will be issued in lieu of a refund.
For Further Information
If you have any questions regarding the conference, please contact Ashley Lemmon at [email protected]
If you have any questions regarding registration, please contact the IPCE Office at [email protected]

Facebook
X
LinkedIn
Forward